miR-125a-5p promotes normal angiogenesis in diabetic foot ulcers by targeting GSTM5

Oct 15, 2025Acta diabetologica

miR-125a-5p helps normal blood vessel growth in diabetic foot ulcers by affecting GSTM5

AI simplified

Abstract

Low expression of both miR-125a-5p and GSTM5 is associated with impaired angiogenesis in chronic diabetic foot ulcer patients.

  • Distinct expression patterns of miR-125a-5p and GSTM5 were observed between acute and chronic diabetic foot ulcer patients.
  • Low levels of miR-125a-5p and GSTM5 in chronic patients correlated positively with changes in angiogenic markers.
  • Inhibition of miR-125a-5p and GSTM5 in endothelial cells in vitro resulted in reduced angiogenesis.
  • MiR-125a-5p is suggested to promote normal angiogenesis in diabetic foot ulcers by targeting GSTM5.

AI simplified

Full Text

Full text is available at the source.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free